Azuma I
Institute of Immunological Science, Hokkaido University, Sapporo, Japan.
Kekkaku. 1996 Jan;71(1):19-23.
The U.S.-Japan Medical Cooperative Program has been started in 1965 and Tuberculosis Panel is one of the most important field of the programs. In this lecture, the recent advances in the basic studies on tuberculosis researches which were reported in Tuberculosis panel of the program were summarized. The host defence mechanisms against M. tuberculosis infection were the most important subject. The role of Th1-mediated cytokins such as IL-2, IFN gamma and TNF beta in the host-defence mechanism against mycobacterial infection was extensively discussed. Bcg gene of the mice is the example case for the genetic background of host against mycobacterial infection. The virulence factor, however of M. tuberculosis is still unknown. The technique of molecular biology was applied to the diagnosis of tuberculosis. The PCR and RFLP methods are the useful strategies for the rapid diagnosis and analysis of the mode of infection with M. tuberculosis. The development of detection techniques of drug-resistant tubercle bacilli is also urgently required. Another approach by molecular biology to tuberculosis research is the cloning of gene of tuberculin protein and the production recombinant protein of M. tuberculosis. The amino acid sequences of several proteins have been determined and their immunological properties of recombinant proteins were investigated. The immunological functions of lipid fractions of tubercle bacilli such as cord factor (TDM) and lipoarabinomannan (LAM) have been described. Especially the immunomodulating activities and the role of TDM as diagnostic antigen in the tuberculosis patients were described. The adjuvant activity of mycobacterial cell wall was well established and the minimum structural requirement was reported to be N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP). The several MDP derivatives were selected as the cytokine inducers. Especially MDP-Lys (L18) was widely used as drug for the increasing the number of white blood cells and platelets in cancer patients. The effectiveness of MDP derivatives on the stimulating of mucosal immunity was also recently reported. The preventing activities of virus infection and cancer metastasis of MDP derivatives were shown in mice models.
美日医学合作项目始于1965年,结核病专题小组是该项目最重要的领域之一。在本次讲座中,总结了该项目结核病专题小组所报告的结核病基础研究的最新进展。宿主针对结核分枝杆菌感染的防御机制是最重要的课题。广泛讨论了白细胞介素-2、干扰素γ和肿瘤坏死因子β等Th1介导的细胞因子在宿主抗分枝杆菌感染防御机制中的作用。小鼠的卡介苗基因是宿主抗分枝杆菌感染遗传背景的实例。然而,结核分枝杆菌的毒力因子仍然未知。分子生物学技术被应用于结核病的诊断。聚合酶链反应(PCR)和限制性片段长度多态性(RFLP)方法是快速诊断和分析结核分枝杆菌感染模式的有用策略。耐药结核杆菌检测技术的开发也亟待进行。分子生物学在结核病研究中的另一种方法是克隆结核菌素蛋白基因并生产结核分枝杆菌重组蛋白。已确定了几种蛋白质的氨基酸序列,并研究了重组蛋白的免疫特性。描述了结核杆菌脂质成分如索状因子(TDM)和脂阿拉伯甘露聚糖(LAM)的免疫功能。特别是描述了TDM在结核病患者中的免疫调节活性和作为诊断抗原的作用。分枝杆菌细胞壁的佐剂活性已得到充分证实,据报道其最小结构要求为N-乙酰胞壁酰-L-丙氨酰-D-异谷氨酰胺(MDP)。几种MDP衍生物被选为细胞因子诱导剂。特别是MDP-Lys(L18)被广泛用作增加癌症患者白细胞和血小板数量的药物。最近也报道了MDP衍生物对刺激黏膜免疫的有效性。在小鼠模型中显示了MDP衍生物对病毒感染和癌症转移的预防作用。